Thermo Fisher Scientific Launches Automated CTS Compleo System To Streamline Cell Therapy Fill And Finish

Thermo Fisher Scientific Inc., the world leader in serving science,  announced the global launch of the Gibco™ CTS™ Compleo™ Fill ...

April 03, 2026 | Friday | News
Reprogramming the Tumor: Lew Bender on Engineering a New Paradigm in Cancer Therapy

From a basement-born idea to a publicly traded biotech advancing late-stage clinical trials, Lew Bender’s journey reflects both scientific persistenc...

April 02, 2026 | Thursday | Interaction
Thermo Fisher Scientific Launches Next-Generation CHOvantage™ GS Platform to Accelerate Biologics Development Timelines

Thermo Fisher Scientific Inc., the world leader in serving science,  announced a next-generation, integrated cell line development platform that ena...

April 02, 2026 | Thursday | News
ORIC Advances Rinzimetostat To Phase 3 With Strong Efficacy And Safety In Prostate Cancer

Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone...

April 02, 2026 | Thursday | News
Lilly To Acquire Centessa Strengthening OX2R Pipeline For Sleep Wake Disorders

Lilly to gain ownership of Centessa's OX2R agonist pipeline designed to improve outcomes across sleep-wake disorders Centessa’s OX2R agonist pip...

April 02, 2026 | Thursday | News
Galapagos Partners with Gilead to Advance T Cell Engager Gamgertamig in Autoimmune Diseases

New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos  Following this transaction, the Company w...

April 01, 2026 | Wednesday | News
Avacta Doses First Patient in FOCUS-01 Trial of AVA6103, Advancing Tumor-Targeted Oncology Platform

Enrollment underway in second Avacta clinical program at first three specialist U.S. oncology centers Initial data from the trial expected later this ye...

April 01, 2026 | Wednesday | News
Biogen to Acquire Apellis in $5.6B Deal to Strengthen Immunology and Rare Disease Portfolio

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including...

April 01, 2026 | Wednesday | News
4basebio Expands UK Footprint With New Cambridge Innovation and Manufacturing Hub

4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansio...

April 01, 2026 | Wednesday | News
Biocytogen Signs Platform License Agreement with Taisho Pharmaceutical

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and develo...

March 31, 2026 | Tuesday | News
Meiji Seika Pharma Invests in Centivax to Advance Universal Vaccine Platform

Meiji Seika Pharma Co., Ltd. announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company deve...

March 31, 2026 | Tuesday | News
Nuclera Expands eProtein Discovery Platform with GPCR Nanodisc Panel

Enables expression of active GPCRs in 48 hours Panel supports screening to scale-up on eProtein Discovery Nuclera, the biotechnology comp...

March 31, 2026 | Tuesday | News
Otsuka Pharmaceutical Co., Ltd. to Acquire Transcend Therapeutics, Inc. in $1.2 Billion Deal to Advance Next-Generation PTSD Therapies

Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend's portfolio, including the TSND-201 progr...

March 30, 2026 | Monday | News
Mayo Clinic Secures $75 Million Grainger Family Gift to Power Next-Generation Healthcare Campus

Mayo Clinic announces a gift of $75 million from the Thomas and Elizabeth Grainger family to support Bold. Forward. Unbound. in Rochester, Mayo Clinic's ...

March 30, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close